Creative Medical Technology Holdings, Inc. Payments to Acquire Debt Securities, Available-for-sale
Creative Medical Technology Holdings, Inc. (CELZ) reported Payments to Acquire Debt Securities, Available-for-sale of $100.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2024-03-22
- Creative Medical Technology Holdings, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $100.00K.
- Creative Medical Technology Holdings, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|
| 2023-12-31 | $100.00K 10-K · filed 2024-03-22 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |